Kindly MD, Inc. modifies executive compensation

On Monday, Kindly MD , Inc., a health services company, announced modifications to the compensatory arrangements of its top executives and independent directors. The Utah-based company, known for its healthcare services and currently trading at $12.95, filed an 8-K with the Securities and Exchange Commission detailing these changes. The company’s stock has shown remarkable momentum, with a 255% return in the past week and over 1,400% gain in the last six months, according to InvestingPro data.

The company entered into addendums to the existing executive employment agreements with CEO Tim Pickett, CFO Jared Barrera, and COO Adam Cox. These amendments adjusted the stock options and vesting schedules for the executives and included a waiver of rights to future equity in Kindly MD, Inc., Nakamoto Holdings, Inc., or their subsidiaries or affiliates. While the company maintains a healthy current ratio of 2.3 and operates with moderate debt levels, InvestingPro analysis indicates the company is not currently profitable, with a negative EBITDA of $4.02 million in the last twelve months.

Specifically, Pickett was awarded 7,479 stock options set to vest on September 1, 2025, and 28,780 shares of fully vested restricted stock. Barrera received 35,000 stock options with a nine-month vesting period, and Cox was granted 40,000 stock options also to vest over nine months.

Additionally, independent directors Amy Powell, Christian Robinson, and Gary Seelhorst were granted 1,838 shares of fully vested restricted common stock, 538 fully vested stock options, and 2,000 stock options that vest upon a change of control of the company.

All stock options were issued with an exercise price based on the closing price of the company’s common stock on the day before the grant date or higher.

In other events, since May 12, 2025, Kindly MD, Inc. has issued 730,923 shares of common stock following the exercise of warrants by holders, resulting in $4,219,584.33 in proceeds as of May 15, 2025.

The company’s common stock (NASDAQ:KDLY) and tradeable warrants (NASDAQ:KDLYW) are listed on The Nasdaq Stock Market LLC. The information in this article is based on a press release statement.

In other recent news, KindlyMD, Inc. has announced a definitive merger agreement with Nakamoto Holdings Inc., a Bitcoin-native holding company. This strategic partnership aims to establish a Bitcoin treasury strategy, positioning the new entity as a leader in the public market Bitcoin treasury space. The merger includes $510 million in private placement in public equity (PIPE) and $200 million in debt financing, which are expected to close concurrently with the merger. David Bailey, the founder of BTC Inc and UTXO, will lead the combined company as CEO. The merger, which has been unanimously approved by the Boards of Directors of both companies, awaits shareholder approval and is subject to customary closing conditions.

The strategic move into Bitcoin treasury has been met with enthusiasm, with over 200 investors worldwide participating in the PIPE, including institutional participants such as Actai Ventures, Arrington Capital, and Van Eck. The combined company will continue to trade on Nasdaq under the KDLY ticker until it is renamed and assigned a new ticker. KindlyMD’s current CEO, Tim Pickett, views the merger as an expansion of the company’s mission, leveraging Nakamoto’s expertise to create long-term shareholder value. The merger also includes a marketing services agreement with BTC Inc, which will support the combined entity’s operations post-merger.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.